pricing

profitability analyses

Using our wide specialist knowledge of healthcare systems, and your knowledge of the product, we use currently available data on costs and effectiveness of existing treatments approaches and those of a new product or service, we can assess for each EU country of interest for a number of chosen price levels:

• the size of the market;
• competitor products and alternative treatment approaches;
• relevant codes and likely changes to the reimbursement system;
• the chances of successfully overcoming the ‘fourth hurdle’;
• likely management or payor resistance to the offering;
• likely support or opposition from prescribers;
• likely support from patient groups and the media;
• likely market share;
• likely speed of adoption.

We use this information to model the revenue in future years in each market of interest, including a range to reflect any uncertainties in the market and in the performance of the product or service.